IMMUNITRACK ApS: Financial statements 2018
CVR: 32347908
Source: annual report 2018, Danish Business Authority
01/06/2017 – 31/05/2018
IMMUNITRACK ApS (CVR 32347908) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 2,450,285 and a net result of DKK 1,676,895 compared with DKK 238,536 the year before. That is an increase of 140.9% compared with the year before. Equity in the 2018 report amounted to DKK 3,545,083. The solvency ratio was 70.2%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 2,450,285
- Profit/Loss
- DKK 1,676,895
- Equity
- DKK 3,545,083
- Total Assets
- DKK 5,050,053
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 2.5 mio. | 1.7 mio. | 3.5 mio. | 4 |
| 2017 | - | 1 mio. | 239 t. | 288 t. | - |
| 2016 | - | 483 t. | 23 t. | 49 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of June 18, 2018, NATIONALREVISION REGISTREREDE REVISORER A/S has been appointed auditor of IMMUNITRACK ApS.
As of May 18, 2018, Robin William Berryman Campbell has joined the board of directors of IMMUNITRACK ApS.
As of May 18, 2018, Sune Frankild has left the board of directors of IMMUNITRACK ApS.
About IMMUNITRACK ApS
IMMUNITRACK ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 6 employees (2018). In 2024, the company reported a gross profit of DKK 141,975,865 and a net result of DKK 110,009,470 compared with DKK -194,097 the year before. Equity in the 2024 report amounted to DKK 21,211,816.